Alpha Dna Investment Management LLC Sarepta Therapeutics, Inc. Transaction History

Alpha Dna Investment Management LLC

  • $261 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$67.31 - $124.76 $392,551 - $727,600
5,832 New
5,832 $562,000
Q1 2022

May 13, 2022
SELL
$63.15 - $90.42 $1.11 Million - $1.58 Million
-17,522 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$77.28 - $99.42 $1.35 Million - $1.74 Million
17,522 New
17,522 $1.58 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email